Cardiovascular Calcification Market Report 2026

Cardiovascular Calcification Market Overview

• Cardiovascular Calcification market size has reached to $1.9 billion in 2025 • Expected to grow to $2.78 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Rising Cardiovascular Diseases Driving Growth Of The Market Due To Increasing Risk Factors And Early Detection Needs • Market Trend: Targeted Intravascular Shockwave Technologies Transforming Calcified Lesion Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cardiovascular Calcification Market?

Cardiovascular calcification refers to the progressive accumulation of calcium phosphate mineral deposits within the walls of arteries, veins, and heart valves, leading to structural stiffening, loss of elasticity, and impaired mechanical function of cardiovascular tissues. This pathological process disrupts normal blood flow and cardiac performance, significantly increasing the risk of atherosclerosis, valvular stenosis, hypertension, heart failure, and major adverse cardiovascular events. The main product types of cardiovascular calcification management include imaging systems, atherectomy devices, stents, and transcatheter valves. Imaging systems refer to advanced diagnostic equipment used to visualize and assess calcified cardiovascular tissues for accurate treatment planning. These systems support diagnosis methods such as computed tomography calcium scoring, Echocardiography, intravascular ultrasound, and biomarkers. The applications include Coronary Artery Disease, aortic valve stenosis, peripheral artery disease, and chronic kidney disease related vascular calcification, and the end users are hospitals, ambulatory surgical centers, cardiac clinics, and dialysis and nephrology centers.

What Is The Cardiovascular Calcification Market Growth Forecast?

The cardiovascular calcification market size is expected to see strong growth in the next few years. It will grow to $2.78 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for precision cardiovascular diagnostics, rising adoption of AI-assisted imaging analysis, expansion of minimally invasive diagnostic procedures, growing investments in preventive cardiology, increasing focus on early intervention strategies. Major trends in the forecast period include increasing adoption of advanced cardiovascular imaging modalities, rising use of calcium scoring and risk stratification tools, growing integration of AI in diagnostic imaging, expansion of catheter-based diagnostic technologies, enhanced focus on early disease detection.

Global Cardiovascular Calcification Market Segmentation

1) By Product Type: Imaging Systems; Atherectomy Devices; Stents; Transcatheter Valves 2) By Diagnosis: Computed Tomography (CT) Calcium Scoring; Echocardiography; Intravascular Ultrasound; Biomarkers 3) By Application: Coronary Artery Disease; Aortic Valve Stenosis; Peripheral Artery Disease; Chronic Kidney Disease (CKD) Related Vascular Calcification 4) By End User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Dialysis And Nephrology Centers Subsegments: 1) By Imaging Systems: Magnetic Resonance Imaging; Computed Tomography Imaging; Ultrasound Imaging; Nuclear Imaging 2) By Atherectomy Devices: Rotational Atherectomy Devices; Directional Atherectomy Devices; Orbital Atherectomy Devices; Laser Atherectomy Devices 3) By Stents: Drug Eluting Stents; Bare Metal Stents; Bioabsorbable Stents; Balloon Expandable Stents 4) By Transcatheter Valves: Transcatheter Aortic Valves; Transcatheter Mitral Valves; Transcatheter Pulmonary Valves; Transcatheter Tricuspid Valves

What Is The Driver Of The Cardiovascular Calcification Market?

The rising prevalence of cardiovascular diseases is expected to propel the growth of the cardiovascular calcification market going forward. Cardiovascular diseases are conditions that impair the heart and blood vessels, leading to problems such as heart disease, stroke, and high blood pressure. The rise in cardiovascular diseases is driven by sedentary lifestyles and poor dietary habits, which increase risks such as hypertension, obesity, and arterial damage. Cardiovascular calcification helps in cardiovascular diseases by serving as a marker of atherosclerosis and plaque buildup, allowing early detection of heart and vessel damage and guiding preventive or therapeutic interventions. For instance, in August 2025, according to the National Institutes of Health, a US-based government agency, between 2025 and 2050, cardiovascular prevalence is projected to rise by 90%, mortality by 73%, and DALYs by 55%, with deaths increasing from 20.5 million to 35.6 million. Therefore, the rising cardiovascular diseases are driving the growth of the cardiovascular calcification industry.

Key Players In The Global Cardiovascular Calcification Market

Major companies operating in the cardiovascular calcification market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Royal Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Shimadzu Corporation, HeartFlow Inc., Aidoc Ltd., Neusoft Medical Systems Co. Ltd., Medis Medical Imaging Systems B.V., Pie Medical Imaging B.V., Canon Medical Systems Corporation, Keya Medical Technology Co. Ltd., Coreline Soft Co. Ltd., FastWave Medical Inc., Cleerly Inc., United Imaging Healthcare Co. Ltd., Zebra Medical Vision Ltd., Circle Cardiovascular Imaging Inc

Global Cardiovascular Calcification Market Trends and Insights

Major companies operating in the cardiovascular calcification market are focusing on developing innovative solutions, such as targeted intravascular shockwave energy delivery technology, to improve the treatment of heavily calcified lesions by enhancing lesion crossing, vessel compliance, and procedural success rates. Targeted intravascular shockwave energy delivery technology is a catheter-based therapy that emits controlled acoustic pressure waves within blood vessels to fracture calcified plaque while preserving surrounding soft tissue and vessel integrity. For instance, in March 2025, Shockwave Medical Inc., a US-based medical device company, launched a novel forward intravascular lithotripsy platform in the US to transform the treatment of difficult-to-cross calcified lesions. It uses forward sonic pressure waves to fracture calcium in difficult-to-cross calcified peripheral artery lesions without balloon inflation. Its purpose is to enable safe catheter advancement and vessel modification in complex PAD cases such as CLTI, improving outcomes over traditional tools. Key advantages include 99% technical success, minimal complications (1.1% major events), reduced perforation or embolization risks, and enhanced efficiency for below-the-knee treatments, as shown in FORWARD PAD trial data.

What Are Latest Mergers And Acquisitions In The Cardiovascular Calcification Market?

In May 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Shockwave Medical for an undisclosed amount. With this acquisition, Johnson & Johnson aims to enhance its technological capability in treating calcified arterial disease and expand its cardiovascular intervention portfolio by integrating Shockwave’s intravascular lithotripsy (IVL) platforms and pipeline, strengthening its competitive position in calcification-focused therapy segments. Shockwave Medical Inc. is a US-based company that specializes in the treatment of severe cardiovascular calcification using proprietary intravascular lithotripsy (IVL) technology.

Regional Insights

North America was the largest region in the cardiovascular calcification market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cardiovascular Calcification Market?

The cardiovascular calcification market consists of sales of imaging systems, intravascular ultrasound devices, computed tomography scanners, magnetic resonance imaging systems, optical coherence tomography devices, catheter-based diagnostic tools, calcium scoring software, and contrast agents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cardiovascular Calcification Market Report 2026?

The cardiovascular calcification market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular calcification industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.